AmeriFlex Group’s Jazz Pharmaceuticals JAZZ Stock Holding History

AmeriFlex Group’s Portfolio JAZZ Stock Details JAZZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$127K	Sell	549 -43	-7%	-$10.6K	0.04%	304
2026 Q2	$143K	Buy	592 +43	+8%	+$9.42K	0.06%	275
2026 Q1	$104K	Hold	549	–	–	0.05%	269
2025 Q4	$93.3K	Buy	549 +545	+13,625%	+$83.6K	0.05%	292
2025 Q3	$527	Buy	+4	New	+$480	﹤0.01%	1035
2025 Q2	–	Sell	-549	Closed	-$68.2K	–	1181
2025 Q1	$68.2K	Buy	549 +547	+27,350%	+$71.4K	0.03%	402
2024 Q4	$249	Buy	+2	New	+$236	﹤0.01%	1137

Other funds holding JAZZ

BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM

Capital World Investors Los Angeles, California $824B AUM 37.44% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $54.1B AUM 39.29% 1-Year Est. Return

State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return

Franklin Resources San Mateo, California $474B AUM 32.39% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

AmeriFlex Group's JAZZ Position: Q3 2026 in Review

AmeriFlex Group reduced its Jazz Pharmaceuticals (JAZZ) stake by 7.3% in Q3 2026, selling an estimated $10.6K and leaving 549 shares worth $127K. The position accounts for 0.04% of the portfolio, ranked #304.

AmeriFlex Group first reported a position in JAZZ in Q4 2024 and has held it in 7 quarters since. The position peaked at $143K in Q2 2026. 538 funds tracked by Wall St. Rank hold JAZZ as of Q3 2026.

AmeriFlex Group held 549 shares of Jazz Pharmaceuticals worth $127K as of Q3 2026.
AmeriFlex Group sold 43 Jazz Pharmaceuticals shares in Q3 2026, an estimated $10.6K.
Jazz Pharmaceuticals made up 0.04% of AmeriFlex Group's portfolio in Q3 2026, its #304 holding.
AmeriFlex Group first reported a position in Jazz Pharmaceuticals in Q4 2024 and has held it in 7 quarters since.
AmeriFlex Group's Jazz Pharmaceuticals position peaked at $143K in Q2 2026.
538 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q3 2026.

Based on AmeriFlex Group's 13F filing for Q3 2026, filed 13 Nov 2026.